In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-23 of 23 for your search:
Drug:  donor lymphocytes
Find trials that include:  Any drugs shown
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 to 60
Sponsor: Other
Protocol IDs: EK126092000, NCT00460629
2.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 12 to 60
Sponsor: Other
Protocol IDs: CIK#2/2007, NMRC/1097/2006, NCT00460694
3.

Phase: Phase II
Type: Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: UCL-BRD-07-137, BRD/07/137, EUDRACT 2007-003081-18, NCT00720447
4.

Phase: Phase II
Type: Treatment
Status: Active
Age: 8 to 75
Sponsor: NHLBI
Protocol IDs: 090087, 09-H-0087, NCT00859586
5.

Phase: Phase II
Type: Treatment
Status: Approved-not yet active
Age: 16 to 65
Sponsor: Other
Protocol IDs: CRUK-PAIReD, PAIReD, CRUK-PAIReD, EUDRACT-2008-004956-60, EU-20930, UCL/08/0121, NCT00908180
6.

Phase: Phase II
Type: Treatment
Status: Approved-not yet active
Age: 16 to 65
Sponsor: Other
Protocol IDs: CRUK-ReACH, ReACH, CRUK-ReACH, EUDRACT-2008-004956-60, EU-20928, UCL/08/0122, NCT00907036
7.

Phase: Phase II
Type: Diagnostic, Treatment
Status: Active
Age: 6 months to 25 years
Sponsor: NCI
Protocol IDs: UCSF-09082, 09082, NCT00975598
8.

Phase: Phase II
Type: Supportive care, Treatment
Status: Active
Age: 6 months to 25 years
Sponsor: Other
Protocol IDs: CC# 09082, NCT01036009
9.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: Eudract number: 2008-003185-26, NCT01186809
10.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 55
Sponsor: Other
Protocol IDs: BRD 09/6-C, NCT01188174
11.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 to 69
Sponsor: Other
Protocol IDs: UCL/10/0241, CRUK-UCL-PROT4, CRUK-UCL-10/0241, LRF-09041, EU-21081, ProT4 (UCL/10/0241), PROT4, NCT01240525
12.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 11D.570, 2011-101, NCT01532635
13.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: BRD 10/07-H, NCT01541280
14.

Phase: Phase II
Type: Treatment
Status: Approved-not yet active
Age: 18 to 70
Sponsor: Other
Protocol IDs: UCL/10/0411, NCT01597219
15.

Phase: Phase II
Type: Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Other
Protocol IDs: BrUOG 273, NCT01685606
16.

Phase: Phase I
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: 08-0906, NCT00935597
17.

Phase: Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: MIAMI NK, 20100344, NCT01147380
18.

Phase: Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2010LS063, MT2010-10, 1009M89012, NCT01385423
19.

Phase: Phase I
Type: Treatment
Status: Active
Age: 2 to 59
Sponsor: Pharmaceutical / Industry
Protocol IDs: CA-ALT-801-02-08, NCT01478074
20.

Phase: Phase I
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: 36361, NCT01483274
21.

Phase: Phase I
Type: Supportive care, Treatment
Status: Active
Age: 18 to 75
Sponsor: NCI, Other
Protocol IDs: BMT243, NCI-2012-00044, SU-01272012-9028, NCT01523223
22.

Phase: Phase I
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: Pro00003975, NCT01627275
23.

Phase: No phase specified
Type: Treatment
Status: Active
Age: Under 76
Sponsor: Other
Protocol IDs: CDR0000564827, RPCI-I-00703, I 00703, NCT00534118
New Search